Pull the syringe to:
(0.100ml)
Concentration: 5.00 mg/ml
Doses per vial: 30
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
NAD+ 500mg is a nucleotide coenzyme research compound studied in relation to cellular redox biology, energy metabolism, mitochondrial pathway research, sirtuin activity, PARP-related DNA repair models and broader cellular ageing pathway research.
NAD+ stands for nicotinamide adenine dinucleotide. PubChem describes NAD+ as the oxidised form of nicotinamide adenine dinucleotide and notes its role in redox reactions, where it carries electrons from one reaction to another. PubChem also lists NAD+ with the molecular formula C21H27N7O14P2 and molecular weight of approximately 663.4 g/mol.
This product is supplied for laboratory research use only. It is not a medicine, supplement, wellness product, anti-ageing product, energy product, detox product, mitochondrial support product, NAD infusion product or injectable product for human use.
| Product Detail | Information |
|---|---|
| Product name | NAD+ |
| Full name | Nicotinamide adenine dinucleotide |
| Common research names | NAD+, oxidised NAD, beta-nicotinamide adenine dinucleotide |
| Size | 500mg |
| Product type | Nucleotide coenzyme research compound |
| Research category | Cellular Metabolism / Redox Research / Mitochondrial Research |
| Common research interest | NAD+/NADH redox balance, sirtuin pathways, PARP pathways, mitochondrial metabolism and cellular energy research |
| Oxidised/reduced pair | NAD+ / NADH |
| Molecular formula | C21H27N7O14P2 |
| Molecular weight | Approximately 663.4 g/mol |
| Form | Powder or supplier-specific research preparation |
| Intended use | Laboratory research only |
| Human use | Not for human consumption, administration, infusion, injection, supplementation or wellness use |
| Documentation | Certificate of Analysis should be checked before use |
| Component | Research Class | General Research Role |
| Nicotinamide | Vitamin B3-related moiety | Part of the NAD+ structure and redox-active nicotinamide ring |
| Adenine | Nucleobase component | Part of the adenosine portion of NAD+ |
| Ribose units | Sugar components | Form part of the nucleotide structure |
| Phosphate groups | Pyrophosphate linkage | Connect the two nucleotide portions of NAD+ |
| NAD+ | Oxidised coenzyme form | Studied in redox reactions and NAD-dependent enzyme systems |
| NADH | Reduced coenzyme form | Studied alongside NAD+ in NAD+/NADH redox balance |
| Molecular formula | C21H27N7O14P2 | Listed by PubChem for NAD+ |
| Molecular weight | Approximately 663.4 g/mol | Useful for laboratory concentration and molar calculation planning |
Product identity, purity, salt form, assay result, water content, storage conditions and batch information should always be confirmed through supplier documentation and the Certificate of Analysis.
NAD+ is studied as a central coenzyme in cellular metabolism. In redox research, NAD+ can accept electrons and be reduced to NADH, while NADH can donate electrons and be converted back to NAD+. This NAD+/NADH balance is commonly examined in cellular energy, mitochondrial function and metabolic pathway research.
NAD+ is also studied beyond redox chemistry. A PubMed Central review describes NAD+ as an important coenzyme for redox reactions and as an essential cofactor for non-redox NAD+-dependent enzymes, including sirtuins and poly ADP-ribose polymerases, also known as PARPs.
This should be understood as laboratory and research literature context only. It should not be used as a claim that a research-use NAD+ 500mg product is approved, safe or effective for anti-ageing, energy, detox, wellness, mitochondrial support, fatigue, recovery, skin health or human treatment.
| Research Area | NAD+ |
| Main research category | Cellular metabolism and redox research |
| Full name | Nicotinamide adenine dinucleotide |
| Oxidised form | NAD+ |
| Reduced form | NADH |
| Common pathway interest | NAD+/NADH redox balance, mitochondrial metabolism and cellular energy models |
| Enzyme pathway interest | Sirtuins, PARPs and other NAD-dependent enzyme systems |
| Cellular stress interest | DNA repair, oxidative stress and metabolic adaptation research models |
| Evidence limitation | Research context does not make bulk NAD+ products approved for human use |
| Product limitation | Research use only, not approved for human use |
| Feature | NAD+ | NADH |
| Research class | Oxidised coenzyme form | Reduced coenzyme form |
| Redox role | Electron acceptor in redox models | Electron donor in redox models |
| Common research pairing | NAD+/NADH balance | NAD+/NADH balance |
| Main research interest | Cellular metabolism, sirtuins, PARPs and redox signalling | Cellular respiration, mitochondrial electron transport and redox state |
| Human-use claim | Not appropriate for this research product | Not appropriate for research-use products |
| Feature | NAD+ | NMN |
| Research class | Nucleotide coenzyme | NAD+ precursor pathway compound |
| Full name | Nicotinamide adenine dinucleotide | Nicotinamide mononucleotide |
| Research pathway | NAD+/NADH redox balance and NAD-dependent enzymes | NAD+ biosynthesis and precursor pathway research |
| Common SEO risk | Infusion, energy and anti-ageing claims | Longevity, anti-ageing and supplement claims |
| Australian regulatory risk | TGA has specific guidance for NAD, NAD+, NADH and NMN products | TGA has specific requirements for NMN in listed medicines |
| Safer positioning | NAD+ redox research compound | NAD+ precursor pathway research compound |
The TGA has published specific Australian guidance for products sold in Australia that claim to contain or influence NAD, NAD+, NADH or NMN. It states that NAD, NAD+ and NADH are currently not permitted ingredients in listed medicines, and that therapeutic goods referring to NAD, NAD+, NADH or NMN may breach the law if not included in the ARTG, exempted or otherwise authorised.
| Feature | NAD+ | Glutathione |
| Research class | Nucleotide coenzyme | Tripeptide redox compound |
| Common abbreviation | NAD+ | GSH |
| Oxidised/reduced pair | NAD+/NADH | GSH/GSSG |
| Main research interest | Cellular energy metabolism, sirtuins, PARPs and mitochondrial pathways | Thiol redox balance, oxidative stress and detoxification enzyme pathways |
| Common overlap | Redox and mitochondrial research | Redox and oxidative stress research |
| Human-use claim | Not appropriate | Not appropriate |
| Strength | Product Page Positioning |
| NAD+ 100mg | Lower research amount for smaller assay or protocol-specific planning |
| NAD+ 250mg | Mid-size research amount for laboratory concentration planning |
| NAD+ 500mg | Larger research amount for NAD+/NADH, sirtuin, PARP and mitochondrial pathway studies |
| NAD+ 1000mg | Larger bulk research amount where supported by laboratory protocol and documentation |
NAD+ strengths should be treated as product variants, not separate therapeutic claims. If multiple strengths are listed separately, each page should have a strength-specific title, meta description, slug, concentration table and internal links to reduce SEO cannibalisation.
| Common Online Claim | Safer Research-Use Wording |
| Energy boost | Studied in cellular energy metabolism and NAD+/NADH pathway research |
| Anti-ageing | Better framed as ageing-related cellular pathway research, not a human benefit claim |
| Longevity | Not an approved or appropriate product claim |
| Mitochondrial support | Better framed as mitochondrial metabolism research |
| Detox | Not an approved or appropriate product claim |
| Recovery | Not an approved or appropriate product claim |
| Brain support | Better framed as cellular stress and neuro-metabolic pathway research |
| IV NAD therapy | Not suitable for research-use product positioning |
| Wellness infusion | Not suitable for research-use product positioning |
NAD+ 500mg is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for energy, anti-ageing, longevity, fatigue, detox, mitochondrial support, recovery, brain health, immune support, wellness, supplementation, IV therapy, infusion, injection or therapeutic use.
All information on this page is provided for laboratory research and product handling context only.
There is no universal recommended dilution for NAD+ 500mg. Dilution depends on the research protocol, required working concentration, assay design, solvent compatibility, salt form, pH conditions, storage method and validated laboratory procedure.
Because NAD+ is a nucleotide coenzyme research compound rather than a standard signalling peptide, researchers should not assume peptide-style reconstitution methods or injection-style preparation methods are suitable.
For research concentration planning only, the basic formula is:
Total compound amount divided by diluent or solvent volume equals final concentration.
| Diluent or Solvent Added to 500mg Amount | Final Concentration |
| 1mL | 500mg/mL |
| 2mL | 250mg/mL |
| 5mL | 100mg/mL |
| 10mL | 50mg/mL |
| 20mL | 25mg/mL |
| 50mL | 10mg/mL |
| 100mL | 5mg/mL |
| 500mL | 1mg/mL |
These are mathematical research concentration examples only. They are not solubility recommendations, human dosing instructions, injection instructions, infusion instructions or supplementation directions.
Before handling NAD+ 500mg in a laboratory setting, make sure all materials, documentation and clean handling conditions are prepared.
| Item | Purpose |
| Product container | Contains NAD+ research compound |
| Certificate of Analysis | Confirms batch-level testing information |
| SDS or safety documentation | Provides handling, hazard and disposal guidance |
| Suitable research-grade diluent or solvent | Used to prepare a working research solution if compatible |
| pH and buffer compatibility notes | Helps protect research validity |
| Sterile or clean lab consumables | Helps reduce contamination and cross-contamination risk |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Approved disinfectant | Used for bench and handling area preparation |
| Laboratory labels | Records concentration, date, batch and handler details |
| Controlled storage access | Supports correct storage after preparation |
| Chemical or laboratory waste container | Used for compliant waste disposal |
The following is a general laboratory handling framework only. Always follow the product Certificate of Analysis, supplier documentation, SDS, institutional procedures and validated research protocol.
Check the product label, batch number, Certificate of Analysis, SDS, NAD+ form and storage requirements before handling the product.
Use a clean laboratory workspace suitable for handling research compounds. Wear appropriate PPE and disinfect the bench surface and required equipment.
Do not assume every peptide diluent or solvent is suitable. Confirm compatibility through supplier documentation, SDS and the approved research protocol.
Add the selected research-grade diluent or solvent according to laboratory procedure. Avoid uncontrolled splashing, aerosol generation or unnecessary exposure.
Gently mix according to the validated protocol until the compound is dissolved or prepared as required. Do not heat, sonicate, vortex or adjust pH unless the protocol specifically allows it.
Check the preparation for visible particles, cloudiness, precipitation, unusual colour changes or separation. If anything appears abnormal, quarantine the preparation and check supplier documentation.
Label the vial, bottle or aliquots with the product name, concentration, diluent or solvent used, date prepared, batch number and researcher initials.
Place the prepared solution into the required storage condition as soon as possible. Avoid unnecessary temperature cycling, light exposure or repeated freeze-thaw cycles.
Some nucleotide coenzyme research compounds may not dissolve easily at higher concentrations. Solubility should always be handled according to validated laboratory protocol.
| Issue | What It May Indicate | Safer Response |
| Powder remains after mixing | Concentration may be too high or diluent may not be suitable | Check CoA, SDS and protocol |
| Cloudiness appears | Incomplete dissolution or incompatibility | Stop and review preparation method |
| Precipitation occurs | Solubility, pH or concentration issue | Reassess working concentration and solvent |
| Colour change | Possible degradation, oxidation or contamination | Do not continue without supplier guidance |
| Separation occurs | Vehicle or preparation incompatibility | Quarantine and review documentation |
| Product identity unclear | NAD+, NADH or salt-form confusion | Stop and confirm CoA before using |
| Storage Factor | Guidance |
| Product form | Dry research compound or supplier-specific preparation |
| Storage condition | Follow supplier label, CoA and SDS |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Oxidation control | Minimise unnecessary exposure where relevant |
| Temperature changes | Avoid repeated temperature cycling |
| Handling | Minimise unnecessary opening and exposure |
| Storage Factor | Guidance |
| Storage condition | Follow validated research protocol |
| Labelling | Record concentration, diluent or solvent, date and batch number |
| Redox form tracking | Record whether the preparation is intended for NAD+ or NADH-related research |
| pH or buffer tracking | Record buffer system or pH conditions where relevant |
| Freeze-thaw cycles | Avoid repeated freeze-thaw exposure where relevant |
| Aliquoting | Use small research aliquots where appropriate |
| Light exposure | Protect from unnecessary light exposure if required |
| Contamination control | Use clean laboratory technique |
| Disposal | Dispose according to laboratory waste procedures |
NAD+ preparations may be sensitive to temperature, light, pH, oxidation, solvent conditions and contamination. Storage conditions should be confirmed through supplier documentation or the laboratory’s validated method.
This page does not provide human dosing, injection instructions, infusion instructions, IV preparation instructions, supplementation instructions or administration guidance.
NAD+ 500mg is not supplied for human or animal administration. It is a laboratory research-use product only.
For research settings, any measured aliquots should be prepared according to the concentration required by the approved research protocol. All calculations should be checked, documented and traceable.
| Planning Item | What to Record |
| Final concentration | Total NAD+ amount and diluent or solvent volume |
| Working solution | Concentration used in the research protocol |
| Aliquot volume | Volume transferred into each labelled lab container |
| Batch details | Product batch, CoA and preparation date |
| NAD form | NAD+, NADH or supplier-specific form |
| Solvent or diluent | Exact solvent, percentage and preparation method |
| pH or buffer details | Buffer system or pH conditions if relevant |
| Storage location | Fridge, freezer, desiccator or other controlled storage area |
| Handler details | Researcher name or initials |
| Preparation date | Date and time of preparation |
| Disposal date | When the aliquot should no longer be used |
| Strength check | Confirmation that the 500mg amount matches the approved research protocol |
Correct handling is important for research consistency, contamination control, redox stability and product traceability. Most mistakes occur when products are not labelled clearly, NAD+ and NADH are confused, solvent compatibility is assumed, concentration calculations are not recorded or storage conditions are not followed.
Because NAD+ is commonly promoted online in relation to anti-ageing, energy, detox, longevity and IV wellness infusions, product pages should avoid wording that could be interpreted as encouraging human self-use, injection, infusion, cosmetic use, therapeutic use or supplementation.
The TGA has specifically warned that listed medicines cannot currently use NAD, NAD+ or NADH as permitted ingredients, and that advertising or supplying therapeutic goods referring to NAD, NAD+, NADH or NMN without ARTG inclusion or another lawful authorisation is likely to breach the law.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Review the SDS | Supports safe chemical handling and disposal |
| Confirm whether it is NAD+ or NADH | Helps avoid redox-form confusion |
| Confirm salt form and assay result | Supports accurate research calculations |
| Confirm solvent compatibility | Prevents failed preparation or invalid research results |
| Use PPE | Reduces exposure and contamination risk |
| Label every container and aliquot | Prevents mix-ups |
| Record concentration calculations | Supports traceability |
| Record buffer or pH conditions | Important for redox and assay consistency |
| Use clean laboratory technique | Reduces contamination risk |
| Follow institutional protocols | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect compound integrity |
| Dispose of lab waste correctly | Supports safety and compliance |
| Use research-use wording only | Reduces misleading human-use interpretation |
| Never | Why It Is Risky |
| Never use for self-injection or infusion | Product is research use only |
| Never sell or promote as an anti-ageing product | Creates human-use and compliance risk |
| Never make energy, fatigue or wellness claims | Not an approved or appropriate product claim |
| Never promote as an IV therapy or infusion product | Not suitable for a research-use product page |
| Never market as detox or mitochondrial support | Not an approved or appropriate product claim |
| Never make longevity claims | Creates misleading human-use interpretation |
| Never assume NAD+ and NADH are interchangeable | They are different redox forms |
| Never assume solvent compatibility | Preparation depends on protocol and product form |
| Never assume purity without CoA | Batch quality must be documented |
| Never use a damaged or unlabelled container | Identity and integrity may be uncertain |
| Never leave prepared solutions unlabelled | Creates traceability risk |
| Never rely on social media, wellness clinic or IV infusion protocols | They may be inaccurate, unsafe or non-compliant |
The table below is for concentration planning only. It does not represent dosage, injection quantity, infusion quantity, supplementation guidance or wellness-use instructions.
| Total Product Amount | Diluent or Solvent Volume | Final Concentration |
| 500mg | 1mL | 500mg/mL |
| 500mg | 2mL | 250mg/mL |
| 500mg | 5mL | 100mg/mL |
| 500mg | 10mL | 50mg/mL |
| 500mg | 20mL | 25mg/mL |
| 500mg | 50mL | 10mg/mL |
| 500mg | 100mL | 5mg/mL |
| 500mg | 500mL | 1mg/mL |
If a researcher adds 50mL of a suitable validated research diluent to 500mg of NAD+, the resulting concentration is 10mg/mL.
This calculation is for research concentration planning only. It is not a human or animal dosing example, injection example, infusion example or supplementation instruction.
NAD+ stands for nicotinamide adenine dinucleotide. It is a nucleotide coenzyme studied in relation to cellular redox balance, cellular metabolism, mitochondrial pathway research and NAD-dependent enzyme systems.
No. NAD+ is not a peptide. It is a nucleotide coenzyme research compound. It may appear in peptide research catalogues because it is often grouped with cellular metabolism, mitochondrial and longevity pathway research products.
NAD+ is studied as an oxidised coenzyme involved in redox reactions and as a cofactor for NAD-dependent enzyme systems such as sirtuins and PARPs.
No. NAD+ is the oxidised form and NADH is the reduced form. They are connected through redox reactions, but they should not be treated as interchangeable research materials.
No. NAD+ is nicotinamide adenine dinucleotide, while NMN is nicotinamide mononucleotide. NMN is commonly studied as part of NAD+ precursor pathway research.
This research product is not approved or supplied for anti-ageing, energy, fatigue, longevity, detox, IV therapy, wellness infusion, injection, supplementation or human administration. It should be described only as a laboratory research product.
The TGA states that NAD, NAD+ and NADH are currently not permitted ingredients in listed medicines, and products making NAD-related claims without an AUST number may be unapproved goods or illegally supplied.
A Certificate of Analysis provides batch-level testing information. It helps researchers verify product identity, purity, form, assay result, salt form and quality documentation before use in a research setting.
| Resource | Why It Is Useful |
| PubChem NAD+ compound profile | Useful background on NAD+ identity, molecular formula and molecular weight. |
| PubChem Nadide profile | Useful background on oxidised nicotinamide adenine dinucleotide and redox role. |
| NAD+ metabolism and cellular processes review | Useful background on NAD+ redox biology, sirtuins, PARPs and cellular metabolism research. |
Research Use Only: NAD+ 500mg is supplied strictly for laboratory research purposes. It is not intended for human or animal consumption, injection, infusion, therapeutic use, cosmetic use, diagnostic use, anti-ageing, energy enhancement, fatigue, detox, longevity, mitochondrial support, wellness, IV therapy, supplementation, body enhancement or performance enhancement. Information on this page is provided for research education and product handling context only. This page does not provide dosing, injection, infusion, IV preparation or administration guidance. Always follow applicable laws, institutional procedures, supplier documentation, SDS guidance and qualified laboratory protocols.
Find research peptides, certificate documentation, guides and key product categories in one clean menu.